As shown in Figure 1G–1I and Figure 1M, compared to the normal group, PLCL1 expression in tumour samples was significantly decreased at the mRNA and protein levels, and similar results were observed between HK2 and RCC cell lines (Figure 1J–1L). The gene discussed is PLCL1; the disease is neoplasm.